Back to Our people

David Hammond

David Hammond

Partner

UK and European Patent Attorney | UPC Representative

Location
Bristol (UK)

About David

David is a partner in the Chemistry and Life Sciences team. With degrees in both chemistry and DNA technology, David is many of our clients’ go-to attorney for innovations in the medical area. He advises our clients on a range of healthcare technologies including diagnostics and biomarkers, small molecule drugs, microfluidics and medical devices. David is equally comfortable advising on inventions that lie mainly in the chemistry area, including inks and printing components, new food compositions and catalysts.

Having spent time on extended secondments with a number of our clients, David has a deep understanding of the in-house environment. For this reason, our clients value his strategic and business-focussed approach, and appreciate the clear, commercially-focussed advice he gives.

David’s strong academic background makes him uniquely placed to head up HLK’s services to universities.

David gained a first class honours Master in Chemistry degree from the University of Sheffield. David then studied for a PhD in Chemical Biology, investigating mechanisms of DNA repair, followed by a two year post-doctoral appointment at the Ludwig-Maximilians Universität in Munich, Germany, developing novel labelling strategies for biomolecular tagging and detection.

David advises multi-nationals, universities, start-ups and SMEs on a broad range of chemistry and biotechnology. Some recent examples of technologies upon which he has advised include: diagnostics for lung disorders, closure devices for sealing punctures in body passageways, biomarkers for colorectal cancer, piperazine derivatives for treating neuropathic and neurodegenerative disorders, acne treatments, and anti-angiogenic treatments.

David’s academic calibre, deep knowledge of patent systems in many countries and commercial approach allow him to draft applications that can secure protection across the world for his clients. David has experience in European patent oppositions and appeals, and helps his clients defend their patents when challenged, and attack their competitors’ patents when required.

While training to be a patent attorney, David was seconded to a large public sector organisation responsible for commercialising research from a range of academic institutions. More recently, as a partner, David has spent time on secondment to a large multinational food manufacturer, as part of their in-house team, helping them with various FTO projects and advising on protection for various new technologies.

David is also involved in coordinating our patent analytical services to clients, which includes invalidity searches, FTO searches, patent mapping and competitor analysis.

David joined the Chemistry and Life Sciences team at HLK in January 2007, and qualified as a UK Patent Attorney in 2011 and as a European Patent Attorney in 2012.

David is fluent in German and has a working knowledge of French.

Legal notice – Haseltine Lake Kempner LLP

Read more
Specialisms
Qualifications

MChem/Eur Chemistry (University of Sheffield)
PhD Biological Chemistry (University of Sheffield)
UK Patent Attorney
European Patent Attorney
UPC Representative

What clients say about David:
For more than 17 years I have engaged Haseltine Lake (now HLK) to provide IP services ranging across patent and trade mark prosecution, IP landscaping, commercialisation contracts and litigation advice. Unfailingly, the level of service and expertise from HLK has been consistently superior to any other IP services provider in any jurisdiction from Asia to the Americas. The range of technical expertise provided across a wide spectrum of science and engineering is complemented by proactive engagement with clients at all stages of prosecution. The level of diligence and conscientiousness is testament to the professionalism of this firm.
— Barry Sturman-Mole, IP & Commercialisation Manager, UK Atomic Energy Authority
Cross icon

Key insights for EPO oppositions: Appeals, data, and G1/23

In our upcoming webinar, our Opposition and Appeal team will be focussing on developments at the EPO’s Boards of Appeal, strategies for maximising success at appeals and take a look at some recent opposition statistics.

Register here